SCHEMBL756333

SCHEMBL756333

CCCN(CCC)CCCCCN

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 9/20 0.52
TSHR P16473 2/20 0.52
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
ALDH1A1 P00352 1/20 0.52
EPHX1 P07099 1/20 0.52
CHRM2 P08172 1/20 0.52
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA3 P07451 2/20 0.42
CA4 P22748 2/20 0.42
CA6 P23280 2/20 0.42
CA5A P35218 2/20 0.42
CA7 P43166 2/20 0.42
CA9 Q16790 2/20 0.42
CA14 Q9ULX7 2/20 0.42
CA5B Q9Y2D0 2/20 0.42
LMNA P02545 1/20 0.42
BLM P54132 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7596162 1.00 DNM1 (0.52) DNM1TSHRMEN1KMT2AALDH1A1
SCHEMBL7593372 1.00 DNM1 (0.52) DNM1TSHRMEN1KMT2AALDH1A1
SCHEMBL7601026 1.00 DNM1 (0.52) DNM1TSHRMEN1KMT2AALDH1A1
SCHEMBL7597228 1.00 DNM1 (0.52) DNM1TSHRMEN1KMT2AALDH1A1
SCHEMBL5892072 1.00 DNM1 (0.52) DNM1TSHRMEN1KMT2AALDH1A1
SCHEMBL7597792 1.00 DNM1 (0.52) DNM1TSHRMEN1KMT2AALDH1A1
SCHEMBL5891998 1.00 DNM1 (0.52) DNM1TSHRMEN1KMT2AALDH1A1
SCHEMBL1205042 1.00 DNM1 (0.52) DNM1TSHRMEN1KMT2AALDH1A1
SCHEMBL5891984 1.00 DNM1 (0.52) DNM1TSHRMEN1KMT2AALDH1A1
SCHEMBL6752966 1.00 DNM1 (0.52) DNM1TSHRMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240240000-A1 POLYISOBUTENE DERIVATIVES AS AN ADDITIVE IN RUBBERS BASF SE (DE) 2024-07-18 US disclosed
EP-4326813-A1 POLYISOBUTENE DERIVATIVES AS AN ADDITIVE IN RUBBERS BASF SE (DE) 2024-02-28 EP disclosed
CN-117242133-A Polyisobutylene derivatives as additives in rubber 巴斯夫欧洲公司 2023-12-15 CN disclosed
US-9938479-B2 Use of amines and/or Mannich adducts in fuel and lubricant compositions for direct-injection spark ignition engines BASF SE (DE) 2018-04-10 US disclosed
EP-1828354-B1 HYDROCARBYL SUCCINIC ACID AND HYDROCARBYLSUCCINIC ACID DERIVATIVES AS FRICTION MODIFIERS BASF SE (DE) 2017-09-06 EP disclosed
US-20160222309-A1 USE OF AMINES AND/OR MANNICH ADDUCTS IN FUEL AND LUBRICANT COMPOSITIONS FOR DIRECT-INJECTION SPARK IGNITION ENGINES BASF SE (DE) 2016-08-04 US disclosed
US-9309475-B2 Use of amines and/or Mannich adducts in fuel and lubricant compositions for direct injection spark ignition engines BASF SE (DE) 2016-04-12 US disclosed
EP-1262500-B1 Catalyst for production of a polyurethane resin and method for producing a polyurethane resin TOSOH CORP (JP) 2015-12-30 EP disclosed
US-20130237466-A1 USE OF AMINES AND/OR MANNICH ADDUCTS IN FUEL AND LUBRICANT COMPOSITIONS FOR DIRECT INJECTION SPARK IGNITION ENGINES BASF SE (DE) 2013-09-12 US disclosed
US-8449630-B2 Use of amines and/or Mannich adducts in fuel and lubricant compositions for direct injection spark ignition engines BASF SE (DE) 2013-05-28 US disclosed
EP-0658111-B1 METHODS FOR ENHANCING DRUG DELIVERY WITH MODIFIED SAPONINS CAMBRIDGE BIOTECH CORP (US) 1999-10-13 EP disclosed
EP-0841932-A4 DRUG DELIVERY ENHANCEMENT VIA MODIFIED SAPONINS AQUILA BIOPHARM INC (US) 1998-12-30 EP disclosed
EP-0841932-A1 DRUG DELIVERY ENHANCEMENT VIA MODIFIED SAPONINS Aquila Biopharmaceuticals, Inc. (US) 1998-05-20 EP disclosed
US-5650398-A PLANT EXTRACTS AND DRUG DELIVERY CAMBRIDGE BIOTECH CORPORATION (US) 1997-07-22 US disclosed
WO-1996038161-A1 DRUG DELIVERY ENHANCEMENT VIA MODIFIED SAPONINS AQUILA BIOPHARMACEUTICALS, INC. (US) 1996-12-05 WO disclosed
EP-0658111-A4 METHODS FOR ENHANCING DRUG DELIVERY WITH MODIFIED SAPONINS. CAMBRIDGE BIOTECH CORP (US) 1996-02-07 EP disclosed
US-5443829-A For enhancing delivery of drugs across mucous membranes of animals CAMBRIDGE BIOTECH CORPORATION (US) 1995-08-22 US disclosed
EP-0658111-A1 METHODS FOR ENHANCING DRUG DELIVERY WITH MODIFIED SAPONINS CAMBRIDGE BIOTECH CORPORATION (US) 1995-06-21 EP disclosed
WO-1994001118-A1 METHODS FOR ENHANCING DRUG DELIVERY WITH MODIFIED SAPONINS CAMBRIDGE BIOTECH CORPORATION (US) 1994-01-20 WO disclosed
US-5273965-A A reduced and hydrolyzed saponin from a Quillaja saponaria extract CAMBRIDGE BIOTECH CORPORATION (US) 1993-12-28 US disclosed